The Road To Commercialization: Small Company Considerations

By Megan Marshal

Making the transition from an R&D company to a fully integrated commercial organization is no small feat. In fact, this is often a make-or-break scenario for biotech companies. Over the last 10 years, the commercialization landscape has changed drastically. With roughly 70 percent of product launches failing to meet their predicted forecasts, it’s obvious that regulatory approvals generated from high-quality and innovatively marketed products alone don’t guarantee a successful bridge into commercialization.